雌激醇调节了在绝经前期抑郁症中的静止状态连接性
Megan Hynd1, Kathryn Gibson2, Melissa Walsh2
1Department of Psychology & Neuroscience, University of North Carolina, Chapel Hill, NC, United States of America.
Journal of affective disorders
|November 24, 2024
概括
通过改变大脑连接,雌激醇 (E2) 治疗显示出对绝经前期抑郁症的前景. 这项研究发现,E2在患有绝经前期发作的MDD的女性中改变了休息状态功能连接 (rsFC),将这些变化与症状改善联系起来.
科学领域:
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
- 精神病学是一个精神病学.
背景情况:
- 经更年期过渡增加了情感失调和严重抑郁症 (MDD) 的风险.
- 雌激醇 (E2) 替代疗法是对经更年期开始的MDD (PO-MDD) 的潜在治疗方法,但其神经机制尚不清楚.
- 以前的研究表明,E2通过调节皮质-皮质下大脑连接来影响情绪.
研究的目的:
- 研究经皮E2对绝经前妇女静止状态功能连接 (rsFC) 的影响.
- 为了比较在E2治疗之前和之后的PO-MDD和没有PO-MDD的女性的rsFC模式.
- 探索E2诱导的rsFC变化和情绪症状轨迹之间的关系.
主要方法:
- 药物-fMRI研究涉及16名PO-MDD妇女和18名对照.
- rsFC分析是在通过皮肤给药E2三周之前和之后进行的.
- 种子区域是在奖励和情绪处理网络 (杏仁体,尾状核,膜) 中选择的.
主要成果:
- 治疗前:PO-MDD组与对照组相比显示了杏仁体连接的改变.
- 治疗后:E2给药诱导了PO-MDD组的rsFC显著变化,包括尾状核,面和杏仁体的连接性变化.
- 连接性变化预测了无情,抑郁情绪,体力和血管运动领域的症状改善.
结论:
- 明显的rsFC模式是PO-MDD的特征,这些模式在E2治疗时会发生变化.
- E2治疗可以通过调节皮层-皮下功能连接来缓解PO-MDD的症状.
- 这些发现提供了对E2在绝经前抑郁症中调节情绪效应背后的神经机制的见解.
更多相关视频
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
12.1K
08:42Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression
Published on: May 19, 2015
10.4K
相关概念视频
Menopause
138
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
138
Hormonal Regulation of the Menstrual Cycle
296
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
296
Depressive Disorders: Etiology
49
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
49
Antidepressant Drugs: MAOIs and Other Agents
194
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
194
Depression: Overview
216
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
216
